GB1498261A - Influenza vaccines - Google Patents

Influenza vaccines

Info

Publication number
GB1498261A
GB1498261A GB1290/75A GB129075A GB1498261A GB 1498261 A GB1498261 A GB 1498261A GB 1290/75 A GB1290/75 A GB 1290/75A GB 129075 A GB129075 A GB 129075A GB 1498261 A GB1498261 A GB 1498261A
Authority
GB
United Kingdom
Prior art keywords
influenza
components
virus
type
cationic detergent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1290/75A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of GB1498261A publication Critical patent/GB1498261A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
GB1290/75A 1974-01-14 1975-01-13 Influenza vaccines Expired GB1498261A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH44774A CH589453A5 (https=) 1974-01-14 1974-01-14

Publications (1)

Publication Number Publication Date
GB1498261A true GB1498261A (en) 1978-01-18

Family

ID=4187233

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1290/75A Expired GB1498261A (en) 1974-01-14 1975-01-13 Influenza vaccines

Country Status (27)

Country Link
JP (2) JPS58407B2 (https=)
AT (1) AT345449B (https=)
AU (1) AU500250B2 (https=)
BE (1) BE824372A (https=)
CA (1) CA1049406A (https=)
CH (1) CH589453A5 (https=)
CS (1) CS191254B2 (https=)
DD (1) DD116239A5 (https=)
DE (1) DE2500785B2 (https=)
DK (1) DK140003B (https=)
ES (1) ES433759A1 (https=)
FI (1) FI54053C (https=)
FR (1) FR2257305B1 (https=)
GB (1) GB1498261A (https=)
HK (1) HK56380A (https=)
HU (1) HU173920B (https=)
IE (1) IE40794B1 (https=)
IL (1) IL46426A (https=)
MY (1) MY8100204A (https=)
NL (1) NL166622C (https=)
NO (1) NO143128C (https=)
PH (1) PH14458A (https=)
PL (1) PL93689B1 (https=)
SE (1) SE427238B (https=)
SU (1) SU616997A3 (https=)
YU (1) YU41289B (https=)
ZA (1) ZA75259B (https=)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6793928B1 (en) 1997-11-25 2004-09-21 Duphar International Research Bv Vaccines with an LTB adjuvant
WO2009029695A1 (en) * 2007-08-28 2009-03-05 Baxter International Inc. Method for producing viral vaccines
WO2015071177A1 (en) 2013-11-15 2015-05-21 Novartis Ag Removal of residual cell culture impurities

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2829089A1 (de) * 1977-07-13 1979-02-01 Sandoz Ag Subunit-vakzine
JPH0688911B2 (ja) * 1985-06-06 1994-11-09 国立予防衛生研究所長 インフルエンザワクチン及びその製造方法
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
DE19938767C2 (de) * 1999-08-16 2002-10-24 Tad Pharma Gmbh Spaltimpfstoffe
ES2525518T3 (es) * 2005-11-01 2014-12-26 Novartis Vaccines And Diagnostics Gmbh Vacunas virales derivadas de células con niveles reducidos de ADN celular residual

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6793928B1 (en) 1997-11-25 2004-09-21 Duphar International Research Bv Vaccines with an LTB adjuvant
WO2009029695A1 (en) * 2007-08-28 2009-03-05 Baxter International Inc. Method for producing viral vaccines
US8497112B2 (en) 2007-08-28 2013-07-30 Baxter International Inc. Method for producing viral vaccines
RU2496519C2 (ru) * 2007-08-28 2013-10-27 Бакстер Интернэшнл Инк. Способ получения препарата, содержащего вирусные антигены, и применение препарата
AU2008293513B2 (en) * 2007-08-28 2013-11-21 Alachua Government Services, Inc. Method for producing viral vaccines
WO2015071177A1 (en) 2013-11-15 2015-05-21 Novartis Ag Removal of residual cell culture impurities

Also Published As

Publication number Publication date
FI54053C (fi) 1978-10-10
DK1475A (https=) 1975-09-01
CS191254B2 (en) 1979-06-29
AU7730575A (en) 1976-07-15
IE40794L (en) 1975-07-14
JPS58407B2 (ja) 1983-01-06
SU616997A3 (ru) 1978-07-25
CA1049406A (en) 1979-02-27
AT345449B (de) 1978-09-11
FI54053B (fi) 1978-06-30
YU5875A (en) 1984-04-30
CH589453A5 (https=) 1977-07-15
NL166622C (nl) 1981-09-15
NO750031L (https=) 1975-08-11
NO143128B (no) 1980-09-15
NL7500301A (nl) 1975-07-16
ES433759A1 (es) 1977-02-16
DD116239A5 (https=) 1975-11-12
DE2500785B2 (de) 1980-01-03
BE824372A (fr) 1975-07-14
JPS50100224A (https=) 1975-08-08
ATA21475A (de) 1978-01-15
NO143128C (no) 1980-12-29
ZA75259B (en) 1976-08-25
FR2257305A1 (https=) 1975-08-08
HK56380A (en) 1980-10-16
JPS6035326B2 (ja) 1985-08-14
PL93689B1 (https=) 1977-06-30
JPS56127319A (en) 1981-10-06
DE2500785A1 (de) 1975-07-31
DK140003C (https=) 1979-10-29
AU500250B2 (en) 1979-05-17
DE2500785C3 (https=) 1980-09-11
FI750014A7 (https=) 1975-07-15
IL46426A0 (en) 1975-04-25
MY8100204A (en) 1981-12-31
HU173920B (hu) 1979-09-28
IL46426A (en) 1978-01-31
DK140003B (da) 1979-06-05
PH14458A (en) 1981-07-29
YU41289B (en) 1987-02-28
IE40794B1 (en) 1979-08-15
NL166622B (nl) 1981-04-15
FR2257305B1 (https=) 1982-03-19
SE427238B (sv) 1983-03-21
SE7500130L (https=) 1975-07-15

Similar Documents

Publication Publication Date Title
DE69128782D1 (de) Oraler an der oberfläche von erythrozyten gebundene antigene beinhaltender impfstoff
HU9401056D0 (en) Porcine reproductive respiratory syndrome vaccine and diagnostic
GB1498261A (en) Influenza vaccines
Haslam et al. The structural proteins of Newcastle disease virus
KR850001700A (ko) 단순 헤르페스 바이러스 서브유니트 왁진(Herpes Simplex Virus Subuait Vaccine)의 제조방법
GB1183506A (en) New vaccines for combating influenza and the preparation thereof
ES469225A1 (es) Procedimiento para potenciar la accion de las vacunas.
ES8104405A1 (es) Procedimiento para preparar una vacuna de virus de gripe
ES430415A1 (es) Un procedimiento para preparar una vacuna de virus de la gripe atenuado.
GB2001326A (en) Glycoproteins from paramyxovirus and vaccines therefrom
Wilcox et al. Soluble Antigens of Vaccinia-infected Mammalian Cells II. Time Course of Synthesis of Soluble Antigens and Virus Structural Proteins
GB1488800A (en) Influenza vaccines
Mims Rift Valley fever virus in mice. II. Adsorption and multiplication of virus
GB1256457A (en) Diethylaminoethyldextran (deae-d) as adjuvant for vaccines for active immunisation
GB660109A (en) Improvements in or relating to the treatment of allantoic fluid containing a propagated virus together with non-viral proteins to obtain the virus in purified and viable from for use in a vaccine
GB1016586A (en) Vaccine for immunization of dogs against distemper and hepatitis contagiosa canis
Greer et al. Electron microscope study of the interaction of vaccinia virus with macrophages from immunized and nonimmunized rabbits
GB1327870A (en) Process for the manufacture of a vaccine against infectious bursitis of chickens
GB1434181A (en) Vaccine for the prevention and treatment of vascular conditions
JP2841592B2 (ja) ウイルス粒子の破砕法
郭元吉 et al. Influenza C virus isolated from pigs in China
EP0374817A3 (en) Method for disrupting virus particles
GB1481650A (en) Chemical processes and products
WO2024186901A3 (en) Broadly reactive immunogens of influenza h3 virus, compositions and methods of use thereof
AR120296A1 (es) Vacuna de partículas de virus de tipo chikungunya y sus métodos de uso

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
732 Registration of transactions, instruments or events in the register (sect. 32/1977)
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19940113